Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase Inhibitor
Clinical trial NCT05198310 · COMPLETED
Trial details
- NCT number
- NCT05198310
- Sponsor
- Kiniksa Pharmaceuticals, Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-14
- Primary completion
- 2024-02-08
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.